Insight Making the most of a better climate – biotech M&A in 2024 M&A transactions entered a period of unprecedented activity in 2021. As the era of uncertainty caused by the pandemic started to ease, deal volume and values exceeded expectations across the globe. Bookmark this page 5 min read
News Acquisition to support the next generation of diagnostic technologies Mills & Reeve has acted for the majority shareholders of Biocrucible, a Cambridge based molecular diagnostics company, on their sale to Sapphiros. Bookmark this page 2 min read
Insight Future Fund popularity continues to rise The UK Government has extended its Future Fund to support high growth companies during the COVID-19 pandemic. Bookmark this page 2 min read
Insight Coronavirus Future Fund popularity continues to rise The UK Government has extended its Future Fund to support high growth companies during the COVID-19 pandemic. Bookmark this page 2 min read